Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, January to March 2022 (text version)
Updated 6 November 2024
Applies to England
© Crown copyright 2024
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/statistics/mrsa-mssa-gram-negative-bacteraemia-and-cdi-quarterly-report/quarterly-infographic-mrsa-mssa-and-gram-negative-bacteraemia-and-cdi-january-to-march-2022-text-version
1. 1. Gram-negative bacteraemias (E. coli, Klebsiella spp. and P. aeruginosa)
1.1 P. aeruginosa bacteraemia
January to March 2021 8 out of every 100,000 persons developed a P. aeruginosa bacteraemia.
January to March 2022 7 out of every 100,000 persons developed a P. aeruginosa bacteraemia.
1.2 Klebsiella spp. bacteraemia
January to March 2021 21 out of every 100,000 persons developed a Klebsiella spp. bacteraemia.
January to March 2022 19 out of every 100,000 persons developed a Klebsiella spp. bacteraemia.
1.3 E. coli bacteraemia
January to March 2021 63 out of every 100,000 persons developed an E. coli bacteraemia.
January to March 2022 64 out of every 100,000 persons developed an E. coli bacteraemia.
2. 2. S. aureus (MRSA and MSSA) bacteraemia and C. difficile infections
2.1 MRSA bacteraemia
January to March 2021 1.5 out of every 100,000 persons developed an MRSA bacteraemia.
January to March 2022 1.3 out of every 100,000 persons developed an MRSA bacteraemia.
2.2 MSSA bacteraemia
January to March 2021 22 out of every 100,000 persons developed an MSSA bacteraemia.
January to March 2022 22 out of every 100,000 persons developed an MSSA bacteraemia.
2.3 C. difficile infection
January to March 2021 21 out of every 100,000 persons developed a C. difficile infection.
January to March 2022 23 out of every 100,000 persons developed a C. difficile infection.